Severity: Warning
Message: file_get_contents(https://...@gmail.com&api_key=61f08fa0b96a73de8c900d749fcb997acc09&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
Filename: helpers/my_audit_helper.php
Line Number: 197
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 197
Function: file_get_contents
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 271
Function: simplexml_load_file_from_url
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3165
Function: getPubMedXML
File: /var/www/html/application/controllers/Detail.php
Line: 597
Function: pubMedSearch_Global
File: /var/www/html/application/controllers/Detail.php
Line: 511
Function: pubMedGetRelatedKeyword
File: /var/www/html/index.php
Line: 317
Function: require_once
98%
921
2 minutes
20
Purpose: Demonstrate intra-tracheal infusion of an adenoviral vector carrying Cre recombinase (AdCre) induces lung tumors in the Oncopig, and verify bronchial arterial yttrium-90 transarterial radioembolization (TARE) as the optimal infusion route for lung cancer.
Materials And Methods: Three transgenic Oncopigs harboring Cre-inducible TP53 and KRAS mutations underwent tumor induction via intra-tracheal AdCre infusion. Tumors were characterized with 2- and 4-week computed tomography and pathology. Five additional Oncopigs underwent tumor induction followed by transarterial technetium-99m macroaggregated albumin (Tc-99m MAA) infusion from bronchial and pulmonary arteries targeting the same tumor with 7 days between procedures. Tc-99m MAA biodistribution was quantified and compared using single-photon emission computed tomography.
Results: Tumor induction was successful in 3/3 Oncopigs. Mean tumor size 2-weeks post-induction was 2.9 x 2.2 cm. Pathology revealed peribronchiolar chronic inflammation, large mass-forming inflammatory cell lesions, and KRAS positivity. Tumor induction was successful in 4/5 additional Oncopigs, with successful Tc-99m MAA tumor targeting from bronchial and pulmonary arteries in all 4 tumor-bearing Oncopigs. Mean tumor-to-normal ratio after bronchial arterial Tc-99m MAA infusion was significantly higher than after pulmonary arterial infusion (8.10±4.30 vs. 2.40±2.15, p=0.032). Esophageal (0.79±0.80 vs. 0.20±0.16, p=0.20), pericardial (8.83±5.34 vs. 5.87±5.15, p=0.43), and spinal cord (0.08±0.09 vs. 0.08±0.08, p=1.0) activities were low and not statistically different between vascular beds. Renal and brain shunt percentages were negligible.
Conclusion: Lung cancer may be generated in the Oncopig, and may be used to characterize biodistribution after transarterial targeting. Bronchial arterial TARE should be prioritized based on higher tumor-to-normal biodistribution.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jvir.2025.08.007 | DOI Listing |